Form EFFECT Atea Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 19, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Euronext intends to nominate David Knibbe as Chief Executive Officer and Chairman of the Managing Board
- 258 Veterans From All Parties Head to the Midterms
- Blokees Becomes an Official Strategic Partner of the Hatsune Miku's "MIKU WITH YOU 2026" Concert in China
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share